Intravenous immunoglobulin therapy;Immunoglobulines intraveineuses en thérapeutique

Revue du Praticien

Volumn 55, Issue 10, 2005, Pages 1049-1056

  Mouthon, Luc ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; IMMUNOGLOBULIN G;

ACUTE KIDNEY FAILURE; ADULT; ANAPHYLAXIS; ANTIPHOSPHOLIPID SYNDROME; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; CEREBROVASCULAR ACCIDENT; CHILD; CHORIORETINOPATHY; DERMATOMYOSITIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; FLUSHING; GUILLAIN BARRE SYNDROME; HEADACHE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HUMAN; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOTHERAPY; INCLUSION BODY MYOSITIS; INFECTION RISK; JUVENILE RHEUMATOID ARTHRITIS; LUNG EMBOLISM; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYASTHENIA; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHY; NEUTROPENIA; POLYMYOSITIS; REVIEW; SIDE EFFECT; STIFF MAN SYNDROME; THROMBOCYTOPENIC PURPURA; THROMBOEMBOLISM; TREATMENT OUTCOME; WHEEZING; COMMON VARIABLE IMMUNODEFICIENCY; METHODOLOGY; PASSIVE IMMUNIZATION;

AUTOIMMUNE DISEASES; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 21344448811     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Imbach P, Barandun S, d'Apuzzo V et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-30.
2. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326: 107-16.
3. Kazatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001;345:747-55.
4. Guilpain P, Chanseaud Y, Tamby MC et al. [Immunomodulatory effects of intravenous immunoglobulins]. Presse Med 2004;33:1183-94.
5. Pirofsky B. Intravenous immune globulin therapy in hypogammaglobulinemia. Am J Med 1984;76:53-60.
6. Eijkhout HW, van Der Meer JW, Kallenberg CG et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001;135:165-74.
7. Chapel H, Lee M, Hargreaves R, Pamphilon DH, Prentice AG. Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. Lancet 1994;343: 1059-63.
8. Griffiths H, Brennen V, Lea J, Bunch C, Lee M, Chapel H. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors. Blood 1989;73:366-8.
9. 9/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. JAMA 1992;268:483-8.
10. Sullivan KM, Kopecky KG, Jocom J et al. Immunomodulatory and anti-microbial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990; 323:705-9.
11. Winston DJ, Antin JH, Wolff SN et al. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001;28:187-96.
12. Cordonnier C, Cnevret S, Legrand H et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 2003;139:8-18.
13. Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000;14:586-91.
14. Koduri PR, Kumapley R, Khokha ND, Patel AR. Red cell aplasia caused by parvovirus B19 in AIDS: use of i.v. immunoglobulin. Ann Hematol 1997; 75:67-8.
15. Mouthon L, Guillevin L, Tellier Z. IVIg in autoimmune or parvovirus B19 mediated pure red cell aplasia (PRCA). Autoimmunity Rev 2005 (Sous presse).
16. Fanaroff A, Korones S, Wright L et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very low birth weight infants. N Engl J Med 1994;330:1107-13.
17. Darenberg J, Ihendyane N, Sjolin J et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37:333-40.
18. Larroche C, Bruneel F, Andre MH et al. [Intravenously administered gamma-globulins in reactive hemaphagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP]. Ann Med Interne (Paris) 2000;151:533-9.
19. Geffray L. Prévention des infections à virus varicelle-zona. Med Mal Infect 1998;28s:746-56.
20. Godeau B, Chevret S, Varet B et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002;359:23-9.
21. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med 1986;315:341-7.
22. Newburger JW, Takahashi H, Beiser AS et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-9.
23. van der Meché FGA, Smith PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326: 1123-9.
24. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Study Group. Ann Neurol 1997;41:789-96.
25. van Koningsveld R, Schmitz PI, Meche FG, Visser LH, Meulstee J, van Doom PA. Effect of methyl-prednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet 2004;363.192-6.
26. Vermeulen M, van Doom PA, Brand A, Strengers PF, Jennekens FG, Busch HF. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993;56:36-9.
27. Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment (IVIg) in chronic inflammatory demyelinating polyneuropathy (CIDP): a double-blind, placebo controlled crossover study. Brain 1996;119:1067-78.
28. Thompson N, Choudhary P, Hughes RA, Quinlivan RM. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996;243:280-5.
29. Mendell JR, Barohn RJ, Freimer ML et al. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001;56:445-9.
30. Dyck PJ, Litchy WJ, Kratz KM et al. A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994;36:838-45.
31. Hughes R, Bensa S, Willison H et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:195-201.
32. Van Schaik IN, Winer JB, De Haan R, Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev 2002 (2): CD001797.
33. Dalakas M, Illa I, Dambrosia J et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
34. Cherin P, Pelletier S, Teixeira A et al. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum 2002;46:467-74.
35. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001;56:323-7.
36. Leger JM, Chassande B, Musset L, Meininger V, Bouche P, Baumann N. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 2001;124 (Pt 1):145-53.
37. Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B. High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 2001;345:1870-6.
38. LeHoang P, Jobin D, Kazatchkine MD. Treatment of birdshot retinochoroidopathy with intravenous immunoglobulins. Am J Ophthalmol 1996 (soumis).
39. Jayne DR, Chapel H, Adu D et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Q J M 2000;93:433-9.
40. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002;2:758-60.
41. Suarez F, Delarue R, Vargaftig J, Hermine O. The interest of administering intravenous immunoglobulins to adults at home. Presse Med. 2004;33:902-3.